TITLE Report from the 2025 Dorothy Russell Havemeyer Foundation meeting on Equine Gastric Ulcer Syndrome (EGUS): Advances in the field. AUTHORS AND AFFILIATIONS Benjamin W. Sykes; b.sykes@uq.edu.au; BW Sykes Consultancy, Coffs Harbour, NSW, Australia. Gayle D. Hallowell: gayle.hallowell@medicine.vet; Medicine Vet Equine Referrals, Melton Mowbray, UK. Frank M. Andrews; fandrews@lsu.edu; Equine Health and Sports Performance, Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisianna State University. The full names of the authors, email addresses, and the institutional affiliations where the work was conducted. KEYWORDS N/A FUNDING INFORMATION Dorothy Russell Havemeyer Research Foundation and Boehringer Ingelheim. ACKNOWLEDGEMENTS N/A CONFLICT OF INTERESTS B.W.S. has active consultancy or research engagements with Kelato Australia, Kelato USA, MDS-Vet, MAI Animal Health, and Mayohealth, and within the past 3 years, has provided research, consultancy or educational services for Abbey Laboratories, A-Vet, Health Food Symmetry, Hong Kong Jockey Club, Kentucky Equine Research, and Salfarm Denmark, all of whom have products within the EGUS space. G.D.H. has affiliations with Salfarm Denmark having provided consultancy services; this company has products in the EGUS space. F.M.A. consults and has had funded grants from Boehringer Ingelheim Animal Health, which has medications in the EGUS space. See Section 4.7. If there are none to disclose, please include the following statement below: ‘The authors have declared no conflicting interests’. DATA INTEGRITY STATEMENT N/A ETHICAL ANIMAL RESEARCH N/A INFORMED CONSENT N/A ANTIMICROBIAL STEWARDSHIP POLICY N/A DATA AVAILABILITY STATEMENT Data sharing is not applicable to this article as no new data were created or analysed in this study.